Penumbra, Inc.: Expanding Global Market Access To Catalyze Growth! 

Penumbra, a global healthcare company, reported a robust start to the first quarter of 2024, showcasing notable financial and operational success. The company’s primary focus on thrombectomy products, specifically within the U.S. market, has contributed significantly to its performance, supported by innovative product launches like Lightning Flash and Lightning Bolt. Total revenues for the quarter amounted to $278.7 million, marking a year-over-year increase of 15.4%. This growth is particularly pronounced in the U.S. thrombectomy sector, which soared by 35.2%, driven by substantial market expansion and increased product adoption. The international thrombectomy market also performed well, recording a 10.7% growth compared to the previous year, surpassing expectations even amid challenging comparisons.